165 related articles for article (PubMed ID: 6270517)
1. Rabbit behavioral model of marijuana psychoactivity in humans.
Consroe P; Fish BS
Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
[TBL] [Abstract][Full Text] [Related]
2. Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.
Consroe P; Martin AR; Fish BS
J Med Chem; 1982 May; 25(5):596-9. PubMed ID: 7086846
[TBL] [Abstract][Full Text] [Related]
3. Inheritance of delta 9-tetrahydrocannabinol seizure susceptibility in rabbits.
Fish BS; Consroe P; Fox RR
J Hered; 1981; 72(3):215-6. PubMed ID: 6268703
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of Medical Cannabis.
Amin MR; Ali DW
Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to, and symmetrical cross-tolerance between, cannabinol and delta 9-tetrahydrocannabinol.
Fish BS; Consroe P
Experientia; 1981 Mar; 37(3):295-6. PubMed ID: 6263678
[No Abstract] [Full Text] [Related]
6. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
7. The ontogeny of delta-9-tetrahydrocannabinol responsiveness in the rabbit.
Fish BS; Consroe P
Dev Psychobiol; 1983 Mar; 16(2):147-58. PubMed ID: 6299864
[TBL] [Abstract][Full Text] [Related]
8. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
Colasanti BK; Lindamood C; Craig CR
Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid induced behavioral convulsions in rabbits.
Martin P; Consroe P
Science; 1976 Nov; 194(4268):965-7. PubMed ID: 982057
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
12. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
Karler R; Turkanis SA
Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
[TBL] [Abstract][Full Text] [Related]
13. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Kwiatkowska M; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
[TBL] [Abstract][Full Text] [Related]
14. Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
Consroe P; Jones B; Laird H
Ann N Y Acad Sci; 1976; 281():198-211. PubMed ID: 798523
[No Abstract] [Full Text] [Related]
15. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Szaflarski JP; Bebin EM
Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
[TBL] [Abstract][Full Text] [Related]
16. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
Brady KT; Balster RL
Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
[TBL] [Abstract][Full Text] [Related]
17. Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew).
Rock EM; Parker LA
Behav Neurosci; 2015 Jun; 129(3):368-70. PubMed ID: 26030435
[TBL] [Abstract][Full Text] [Related]
18. Species-specific susceptibility to cannabis-induced convulsions.
Whalley BJ; Lin H; Bell L; Hill T; Patel A; Gray RA; Elizabeth Roberts C; Devinsky O; Bazelot M; Williams CM; Stephens GJ
Br J Pharmacol; 2019 May; 176(10):1506-1523. PubMed ID: 29457829
[TBL] [Abstract][Full Text] [Related]
19. Translational models of cannabinoid vapor exposure in laboratory animals.
Moore CF; Stiltner JW; Davis CM; Weerts EM
Behav Pharmacol; 2022 Apr; 33(2&3):63-89. PubMed ID: 33136615
[TBL] [Abstract][Full Text] [Related]
20. Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats.
Yamaguchi T; Shoyama Y; Watanabe S; Yamamoto T
Brain Res; 2001 Jan; 889(1-2):149-54. PubMed ID: 11166698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
